Intrinsic bias in breast cancer gene expression data sets

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Mosley, Jonathan D ^a   Keri, Ruth A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CLUSTER ANALYSIS; GENE CLUSTER; GENE EXPRESSION REGULATION; INTERNAL BIAS; LATENT PERIOD; METASTASIS; PREDICTION; PROGNOSIS; SAMPLE SIZE; ALGORITHM; BREAST TUMOR; DNA MICROARRAY; EPIDEMIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MULTIGENE FAMILY; PROPORTIONAL HAZARDS MODEL; RANDOMIZATION; STATISTICAL ANALYSIS;

ALGORITHMS; BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; CLUSTER ANALYSIS; DATA INTERPRETATION, STATISTICAL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOM ALLOCATION;

EID: 67651121480     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-214     Document Type: Article

References (35)

1. Wang Y Klijn JG Zhang Y Sieuwerts AM Look MP Yang F Talantov D Timmermans M Meijer-van Gelder ME Yu J et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 2005, 365:671-679. 15721472
2. Miller LD Smeds J George J Vega VB Vergara L Ploner A Pawitan Y Hall P Klaar S Liu ET et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proc Natl Acad Sci USA 2005, 102:13550-13555. 1197273 16141321 10.1073/pnas.0506230102
3. Sorlie T Tibshirani R Parker J Hastie T Marron JS Nobel A Deng S Johnsen H Pesich R Geisler S et al. Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 2003, 100:8418-8423. 166244 12829800 10.1073/pnas.0932692100
4. Vijver van de MJ He YD van't Veer LJ Dai H Hart AA Voskuil DW Schreiber GJ Peterse JL Roberts C Marton MJ et al. A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 2002, 347:1999-2009. 10.1056/NEJMoa021967 12490681
5. Sotiriou C Neo SY McShane LM Korn EL Long PM Jazaeri A Martiat P Fox SB Harris AL Liu ET Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 2003, 100:10393-10398. 193572 12917485 10.1073/pnas.1732912100
6. Sotiriou C Wirapati P Loi S Harris A Fox S Smeds J Nordgren H Farmer P Praz V Haibe-Kains B et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 2006, 98:262-272. 16478745
7. Sotiriou C Desmedt C Gene expression profiling in breast cancer Ann Oncol 2006, 17(Suppl 10):x259-x262. 10.1093/annonc/mdl270 17018735
8. Harris L Fritsche H Mennel R Norton L Ravdin P Taube S Somerfield MR Hayes DF Bast RC Jr American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer J Clin Oncol 2007, 25:5287-5312. 10.1200/JCO.2007.14.2364 17954709
9. Eden P Ritz C Rose C Ferno M Peterson C "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers Eur J Cancer 2004, 40:1837-1841. 10.1016/ j.ejca.2004.02.025 15288284
10. Dunkler D Michiels S Schemper M Gene expression profiling: Does it add predictive accuracy to clinical characteristics in cancer prognosis? Eur J Cancer 2007, 43:745-751. 10.1016/j.ejca.2006.11.018 17257824
11. Gruvberger S Ringner M Chen Y Panavally S Saal LH Borg A Ferno M Peterson C Meltzer PS Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns Cancer Res 2001, 61:5979-5984. 11507038
12. Ivshina AV George J Senko O Mow B Putti TC Smeds J Lindahl T Pawitan Y Hall P Nordgren H et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer Cancer Res 2006, 66:10292-10301. 10.1158/0008-5472.CAN-05-4414 17079448
13. Desmedt C Sotiriou C Proliferation: The most prominent predictor of clinical outcome in breast cancer Cell Cycle 2006, 5:2198-2202. 16969100
14. Mosley JD Keri RA Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists BMC Med Genomics 2008, 1:11. 2396170 18439262 10.1186/1755-8794-1-11
15. van't Veer LJ Dai H Vijver van de MJ He YD Hart AA Mao M Peterse HL van der KK Marton MJ Witteveen AT et al. Gene expression profiling predicts clinical outcome of breast cancer Nature 2002, 415:530-536. 10.1038/ 415530a 11823860
16. Gruvberger SK Ringner M Eden P Borg A Ferno M Peterson C Meltzer PS Expression profiling to predict outcome in breast cancer: The influence of sample selection Breast Cancer Res 2003, 5:23-26 154130 12559041 10.1186/bcr548
17. Ein-Dor L Kela I Getz G Givol D Domany E Outcome signature genes in breast cancer: Is there a unique set? Bioinformatics 2005, 21:171-178. 10.1093/bioinformatics/bth469 15308542
18. Zhang Z Chen D Fenstermacher DA Integrated analysis of independent gene expression microarray datasets improves the predictability of breast cancer outcome BMC Genomics 2007, 8:331. 2064937 17883867 10.1186/ 1471-2164-8-331
19. Fan C Oh DS Wessels L Weigelt B Nuyten DS Nobel AB van't Veer LJ Perou CM Concordance among gene-expression-based predictors for breast cancer N Engl J Med 2006, 355:560-569. 10.1056/NEJMoa052933 16899776
20. Desmedt C Piette F Loi S Wang Y Lallemand F Haibe-Kains B Viale G Delorenzi M Zhang Y d'Assignies MS et al. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series Clin Cancer Res 2007, 13:3207-3214. 10.1158/1078-0432.CCR-06-2765 17545524
21. Haibe-Kains B Desmedt C Piette F Buyse M Cardoso F van't Veer L Piccart M Bontempi G Sotiriou C Comparison of prognostic gene expression signatures for breast cancer BMC Genomics 2008, 9:394. 2533026 18717985 10.1186/1471-2164-9-394
22. McGuire WL Horwitz KB Pearson OH Segaloff A Current status of estrogen and progesterone receptors in breast cancer Cancer 1977, 39:2934-2947. 10.1002/1097-0142(197706)39:6<2934::AID-CNCR2820390680>3.0.CO;2-P 326386
23. Bovelstad HM Nygard S Storvold HL Aldrin M Borgan O Frigessi A Lingjaerde OC Predicting survival from microarray data-a comparative study Bioinformatics 2007, 23:2080-2087. 10.1093/bioinformatics/btm305 17553857
24. Yu JX Sieuwerts AM Zhang Y Martens JW Smid M Klijn JG Wang Y Foekens JA Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer BMC Cancer 2007, 7:182. 2077336 17894856 10.1186/1471-2407-7-182
25. Kim SY Kim YS A gene sets approach for identifying prognostic gene signatures for outcome prediction BMC Genomics 2008, 9:177. 2364634 18416850 10.1186/1471-2164-9-177
26. Dai H van't Veer L Lamb J He YD Mao M Fine BM Bernards R V Deutsch P Sachs A et al. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients Cancer Res 2005, 65:4059-4066. 10.1158/0008-5472.CAN-04-3953 15899795
27. Chang HY Nuyten DS Sneddon JB Hastie T Tibshirani R Sorlie T Dai H He YD van't Veer LJ Bartelink H et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival Proc Natl Acad Sci USA 2005, 102:3738-3743. 548329 15701700 10.1073/pnas.0409462102
28. Naderi A Teschendorff AE Barbosa-Morais NL Pinder SE Green AR Powe DG Robertson JF Aparicio S Ellis IO Brenton JD et al. A gene-expression signature to predict survival in breast cancer across independent data sets Oncogene 2006, 26:1507-1516. 10.1038/sj.onc.1209920 16936776
29. Teschendorff AE Naderi A Barbosa-Morais NL Pinder SE Ellis IO Aparicio S Brenton JD Caldas C A consensus prognostic gene expression classifier for ER positive breast cancer Genome Biol 2006, 7:R101. 1794561 17076897 10.1186/gb-2006-7-10-r101
30. Yasui Y Potter JD The shape of age-incidence curves of female breast cancer by hormone-receptor status Cancer Causes Control 1999, 10:431-437. 10.1023/A:1008970121595 10530614
31. Potter JD Cerhan JR Sellers TA McGovern PG Drinkard C Kushi LR Folsom AR Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: How many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 1995, 4:319-326. 7655325
32. Slamon DJ Clark GM Wong SG Levin WJ Ullrich A McGuire WL Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 1987, 235:177-182. 10.1126/science.3798106 3798106
33. Teschendorff AE Caldas C A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer Breast Cancer Res 2008, 10:R73. 2575547 18755024 10.1186/bcr2138
34. Teschendorff AE Miremadi A Pinder SE Ellis IO Caldas C An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer Genome Biol 2007, 8:R157. 2374988 17683518 10.1186/gb-2007-8-8-r157
35. Michiels S Koscielny S Hill C Prediction of cancer outcome with microarrays: A multiple random validation strategy Lancet 2005, 365:488-492. 10.1016/S0140-6736(05)17866-0 15705458